Ken Griffin Iradimed Corp Transaction History

Citadel Advisors LLC

$509 Billion
Q1 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Iradimed Corp stock. As of the latest transaction made, Citadel Advisors LLC holds 2,400 shares of IRMD stock, worth $105,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,400

Previous 2,400 -0.0%

Holding current value

$105,456

Previous $113,000 7.08%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$41.17 - $47.29 $474,566 - $545,111	11,527 Added 56.99%	31,753 $1.4 Million
Q4 2023 Feb 14, 2024	BUY	$37.31 - $47.47 $100,550 - $127,931	2,695 Added 15.37%	20,226 $960,000
Q3 2023 Nov 14, 2023	SELL	$43.28 - $50.3 $707,454 - $822,203	-16,346 Reduced 48.25%	17,531 $777,000
Q2 2023 Aug 14, 2023	SELL	$38.88 - $50.61 $714,731 - $930,363	-18,383 Reduced 35.18%	33,877 $1.62 Million
Q1 2023 May 15, 2023	BUY	$28.48 - $42.14 $1.06 Million - $1.56 Million	37,115 Added 245.06%	52,260 $2.06 Million

Q4 2022 Feb 14, 2023	BUY	$26.9 - $30.58 $407,400 - $463,134	15,145 New	15,145 $428,000
Q2 2022 Aug 15, 2022	SELL	$30.15 - $45.79 $169,352 - $257,202	-5,617 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$36.01 - $53.14 $52,898 - $78,062	-1,469 Reduced 20.73%	5,617 $252,000
Q3 2021 Nov 15, 2021	BUY	$29.5 - $37.21 $209,037 - $263,670	7,086 New	7,086 $238,000
Q4 2020 Feb 16, 2021	SELL	$20.62 - $25.0 $260,018 - $315,250	-12,610 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$21.0 - $24.61 $233,478 - $273,613	-11,118 Reduced 46.86%	12,610 $270,000
Q2 2020 Aug 14, 2020	BUY	$18.68 - $24.35 $68,779 - $89,656	3,682 Added 18.37%	23,728 $550,000
Q1 2020 May 15, 2020	BUY	$16.08 - $27.67 $322,339 - $554,672	20,046 New	20,046 $428,000

Others Institutions Holding IRMD

# of Institutions

127

Shares Held

6.75M

Call Options Held

7.7K

Put Options Held

View Full List

About IRADIMED CORP

Ticker IRMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 12,565,100
Market Cap $552M
Description
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...

More about IRMD

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account